Inventor · disambiguated record
Jae Gyun Jeong
Also filed as: JEONG JAE GYUN
8 granted patents·4 pending applications·4 citations·filing 2007–2020
76Inventor score
Top patents by PatentIndex Score
12 records- 0174US9963493B2Gene therapy for diabetic neuropathy using an HGF isoformKIM JONG MOOK·Filed 2012·Granted May 8, 2018·2 cites·3 claims
- 0271US11279769B2Anti-Sialyl Tn chimeric antigen receptorsHELIXMITH CO LTD·Filed 2016·Granted Mar 22, 2022·1 cites·25 claims
- 0370US10927177B2Methods of treatment using anti-c-met antibodiesVIROMED CO LTD·Filed 2017·Granted Feb 23, 2021·1 cites·18 claims
- 0468US10759841B2Gene therapy for diabetic neuropathy using an HGF isoformHELIXMITH CO LTD·Filed 2019·Granted Sep 1, 2020·0 cites·2 claims
- 0566US2020354420A1Gene therapy for diabetic neuropathy using an hgf isoformHELIXMITH CO LTD·Filed 2020·Application pending·0 cites
- 0666US2018222955A1Gene therapy for diabetic neuropathy using an hgf isoformVIROMED CO LTD·Filed 2018·Application pending·0 cites
- 0755US11634728B2Adeno-associated virus (AAV) vector having hybrid HGF gene introduced theretoHELIXMITH CO LTD·Filed 2018·Granted Apr 25, 2023·0 cites·3 claims
- 0853US2008069796A1Low Dose Treatment with an Interleukin-11 AnalogKIM JONG-MOOK·Filed 2007·Application pending·0 cites
- 0948US2020271647A1Biomarkers for predicting prognosis of kidney diseaseSEOUL NAT UNIV HOSPITAL·Filed 2019·Application pending·0 cites
- 1044US12180287B2Anti-c-Met antibody showing enhanced stability or antigen-binding fragments thereofHELIXMITH CO LTD·Filed 2019·Granted Dec 31, 2024·0 cites·5 claims
- 1144US10639351B2Method for treating amyotrophic lateral sclerosis with a polynucleotide encoding two or more isoforms of hepatocyte growth factorHELIXMITH CO LTD·Filed 2014·Granted May 5, 2020·0 cites·11 claims
- 1236US11219667B2Method for treating peripheral vascular disease using hepatocyte growth factor and stromal cell derived factor 1AHELIXMITH CO LTD·Filed 2015·Granted Jan 11, 2022·0 cites·9 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →